Correlation Between Ascendis Pharma and Avery Dennison

Can any of the company-specific risk be diversified away by investing in both Ascendis Pharma and Avery Dennison at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ascendis Pharma and Avery Dennison into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ascendis Pharma AS and Avery Dennison, you can compare the effects of market volatilities on Ascendis Pharma and Avery Dennison and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ascendis Pharma with a short position of Avery Dennison. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ascendis Pharma and Avery Dennison.

Diversification Opportunities for Ascendis Pharma and Avery Dennison

0.81

Correlation Coefficient

Ascendis Pharma  Avery Dennison

Very poor diversification

The 3 months correlation between Ascendis and Avery is 0.81. Overlapping area represents the amount of risk that can be diversified away by holding Ascendis Pharma AS and Avery Dennison in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Avery Dennison and Ascendis Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ascendis Pharma AS are associated (or correlated) with Avery Dennison. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Avery Dennison has no effect on the direction of Ascendis Pharma i.e., Ascendis Pharma and Avery Dennison go up and down completely randomly.

Pair Corralation between Ascendis Pharma and Avery Dennison

Assuming the 90 days trading horizon Ascendis Pharma AS is expected to generate 43.57 times more return on investment than Avery Dennison. However, Ascendis Pharma is 43.57 times more volatile than Avery Dennison. It trades about 0.17 of its potential returns per unit of risk. Avery Dennison is currently generating about 0.13 per unit of risk. If you would invest  4,950  in Ascendis Pharma AS on October 20, 2024 and sell it today you would earn a total of  894.00  from holding Ascendis Pharma AS or generate 18.06% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	98.31%
Values	Daily Returns

Ascendis Pharma AS  vs.  Avery Dennison

Ascendis Pharma AS

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Ascendis Pharma AS are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ascendis Pharma sustained solid returns over the last few months and may actually be approaching a breakup point.

Avery Dennison

Risk-Adjusted Performance

10 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Avery Dennison are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite somewhat strong basic indicators, Avery Dennison is not utilizing all of its potentials. The newest stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Ascendis Pharma and Avery Dennison

The main advantage of trading using opposite Ascendis Pharma and Avery Dennison positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ascendis Pharma position performs unexpectedly, Avery Dennison can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Avery Dennison will offset losses from the drop in Avery Dennison's long position.

The idea behind Ascendis Pharma AS and Avery Dennison pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.